CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

CTGCT

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Marketaccess
  • CTGCT
  • NIC
  • Gregor Cuzak
20 May 2025 Event Date: 1 May 2025 do: 31 May 2025 •

Posters at Krakovski nasip – Ljubljanica embankment

In May 2025, our Centre for the Technologies of Gene and Cell Therapy CTGCT) is participating in a poster exhibition on Krakovski nasip, as part of the Chemical Institute’s public presentation.

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Charite Berlin
  • CTGCT
  • NIC
  • TUD
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
19 May 2025 Event Date: 15 May 2025 do: 15 May 2025 •

Review meeting of Reporting Period 1 for the CTGCT

On May 15, 2024, the members of the CTGCT  hosted the review meeting for the Reporting Period 1of its EU-funded project at the Kemijski Inštitut in Ljubljana, in collaboration with representatives from its Advanced Partners

  • Articles
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • Raziskave
  • CTGCT
  • NIC
  • Rodrigo Ortiz
8 April 2025 Event Date: 21 March 2025 do: 21 March 2025 •

CTGCT’s Role in the GeneH Project: Accelerating Gene Therapy Innovations

We are thrilled to announce our participation in the GeneH consortium, an ambitious project led by the University of Coimbra, and their GeneT project, colead by the Kemijski Inštitut with the CTGCT project, aimed ...

  • Events
  • Pacients
  • Business Model
  • Investment
  • CTGCT
  • NIC
  • Rodrigo Ortiz
13 March 2025 Event Date: 12 March 2025 do: 12 March 2025 •

Prime Minister of Slovenia Dr. Robert Golob visits the Kemijski Inštitut to discuss the CTGCT plans

Yesterday, Dr. Robert Golob, Prime Minister of the Slovenian Government, visited the Kemijski inštitut - National Institute of Chemistry.

Pxl 20250313 084506170.mp
  • Events
  • Clinicians
  • Researchers
  • Gen Therapy
  • Research
  • CTGCT
  • Rodrigo Ortiz
12 March 2025 Event Date: 17 March 2025 • 14:00 do: 17 March 2025 • 15:00

Gene Therapy: Triumphs, Challenges, and Future Directions

Lecture by Luis Pereira de Almeida on the 17th of March at the Kemijski Inštitut

Luis Pereira Lecture March 2025
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Manufacturing Process
  • Regulation
  • CTGCT
  • UMCUtrecht
  • Rodrigo Ortiz
5 March 2025

Navigating Viral Vector Production for Gene Therapy

This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ...

Ctgct Scientific Talk March 2025
  • Events
  • Researchers
  • GLP
  • GMP
  • Drug Discovery
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
3 March 2025 Event Date: 10 February 2025 −

Workshop Report: Introduction to 4D-Nucleofector Technology

A hands-on workshop on 4D-Nucleofector technology provided insights into gene transfer using Lonza’s Core- and X units. Participants learned about nucleofection, optimized protocols, and best practices for efficient gene delivery in cell-based research.

20250210 123113
  • Articles
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 February 2025

How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Paving The Way Ctnnb1
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
25 February 2025

Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy

Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ...

Graphical Abstract Controlling Cells
  • Articles
  • Pacients
  • CTGCT
  • Gregor Cuzak
18 February 2025

Hugs for rare

The 28th of February is approaching which is the Day of Rare diseases. Hugs are being collected in 7 countries to raise awareness of the importance of everyone working together to defeat rare diseases.

Hugs1
  • ATMPs
  • Business Model
  • Economics
  • CTGCT
  • UCL
  • Gregor Cuzak
12 February 2025

Introduction to IP and commercialisation – by UCL

The workshop took place on February 3d and was attended by the CTGCT advanced partners only. It provided an in-depth discussion on Intellectual Property (IP) and the process of commercializing research findings. The session ...

  • Events
  • Researchers
  • Cell therapy
  • Laboratory
  • CTGCT
  • Gregor Cuzak
11 February 2025 Event Date: 15 January 2025 do: 16 January 2025 •

Workshop: Introduction to the production of viruses using bioreactor

On 15th January a Sartorius employee gave us a lecture on Ambr250 bioreactor and its accompanying software, which we have on trial. Together we set up the protocol and parameters for our bioprocess (gas ...

20250115 100039

Posts pagination

1 2 3 4 5

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna